𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Seroprevalence of Hepatitis-B infection amongst Taiwanese university students 18 years following the commencement of a national Hepatitis-B vaccination program

✍ Scribed by Fu-Hsiung Su; Jong-Dar Chen; Shu-Hsing Cheng; Ching-Hung Lin; Yi-Hui Liu; Fang-Yeh Chu


Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
110 KB
Volume
79
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

In Taiwan, the nation‐wide Hepatitis‐B virus (HB) vaccination program was first launched in July 1984 and was directed to those infants born to hepatitis B surface antigen (HBsAg) carrier mothers in Taiwan. From July 1986 onwards, all infants born in Taiwan were immunized against HB. This study examined the HB‐infection status amongst students at a Taiwanese university 18 years subsequent to the implementation of universal HB vaccination. A total of 1,969 new university entrants in 2005 were grouped into 1 of 3 distinct birth cohorts according to their HB‐vaccination schedule (cohort‐1 students born prior to July 1, 1984; cohort‐3 students born subsequent to June 30, 1986) and were examined for their serum HBsAg, antibody to hepatitis B surface antigen (anti‐HBs), and antibody to hepatitis B core antigen (anti‐HBc) status. Immunity arising from vaccination was defined as an anti‐HBs level 10 mIU/ml. We observed a trend toward a decreasing anti‐HBc‐positive rate and a decreasing HBsAg carrier rate from, respectively, 26.5 and 8.7% for cohort‐1 to 4.7 and 1.7% for cohort‐3 students. The prevalence of students featuring seronegativity for all three HB markers increased from 12.3% for cohort‐1 to 48.8% for cohort‐3 individuals. Amongst the 1,695 subjects revealing seronegativity for HBsAg and anti‐HBc, their anti‐HBs level was analyzed according to their birth year. The prevalence of students featuring a non‐protective anti‐HBs level increased from 11.9% for birth‐year 1984 individuals to 48.2% for birth‐year 1987 students. The introduction of HB vaccine has effectively reduced the transmission of HBV infection in Taiwan, 18 years subsequent to the commencement of the universal HB‐vaccination program. A “waning‐off” effect of anti‐HBs seropositivity acquired from the HB vaccination program has also been observed. J. Med. Virol. 79:138–143, 2007. © 2006 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Seroprevalence of hepatitis B virus infe
✍ Yee-Jeng Tsen; Mei-Hwei Chang; Hong-Yuan Hsu; Chin-Yun Lee; Juei-Low Sung; Ding- 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 400 KB 👁 1 views

A nationwide hepatitis B vaccination program was launched in Taiwan in 1984. To study the impact of this ongoing program on hepatitis B virus (HBV) infection, a follow-up seroepidemiologic study was carried out in 1989 in a Taipei district where pre-vaccination seroepidemiology had been studied. HBV

A serological and molecular survey of he
✍ Ying Dong; She-Lan Liu; Xiang-Jun Zhai; Feng-Cai Zhu; Hao Pan; Jia-xi Yu; Yin-zh 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 636 KB

## Abstract The emergence of mutations in the hepatitis B virus (HBV) __S__ gene has threatened the long‐term success of vaccination programs since the worldwide introduction of effective vaccines against hepatitis B. This study was conducted on 5,407 children (0–8 years old) in eastern China in 20